Sign in
CompletedPhase 3

Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment

Key facts

Who runs it
Eurofarma Laboratorios S.A.
Where
Brazil2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 3
People taking part
567 people enrolled
Started
26 Mar 2025
Ended
26 Aug 2025
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Experimental drug (paracetamol 500mg / fexofenadine 60mg / phenylephrine 20mg)
  • Placebo
Record updated
26 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Common cold: presence of moderate to severe nasal congestion AND moderate to severe runny nose AND at least one (01) of the following moderate to severe symptoms: sneezing, headache, myalgia, sore throat, throat pain, dysphonia, cough and fever; Duration of symptoms ≤ 48 hours at screening. Informed Consent Form (ICF) signed before carrying out any study procedure

Who cannot take part

  • Presence of nasal polyposis to previous rhinoscopy
  • Known hypersensitivity to any component of the experimental drug formulation
  • Required antibiotic therapy for upper airway infection treatment
  • Presence of significant septum deviation, compatible with impaired nasal ventilatory function, at the investigator's discretion

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A Phase 3, multicenter, Randomized, Double-blind, comparative clinical trial to evaluate the association of paracetamol 500mg + Fexofenadine 60mg + Phenylephrine 20mg in the flu and common cold treatment.

Read full original descriptionShow less

⚠️Study will only be conducted in research centers in Brazil (please do not send e-mail if your center is outside brazil).

The 2 groups in the trial

  • Experimental drug (paracetamol 500mg / fexofenadine 60mg / phenylephrine 20mg)Treatment being tested

    Group 1: paracetamol 500mg / fexofenadine 60mg / phenylephrine 20mg FDC (experimental drug).

  • Placebo groupPlacebo, for comparison

    Group 2: Placebo

    Treatment: Placebo

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multicenter, Randomized, Parallel-group, Double-blind, Comparative Trial of the Superiority of Paracetamol 500mg/Fexofenadine 60mg/Phenylephrine 20mg Fixed-dose Combination Versus Placebo in the Symptomatic Treatment of Flu and Cold
Record updated
26 October 2026